Literature DB >> 22426675

Hormonal therapy for fertility and huge meningioma: a purely random association?

Paolo Frassanito1, Pasquale De Bonis, Pier Paolo Mattogno, Mariangela Novello, Carmelo Anile.   

Abstract

Sexual hormones have been related to the growth of meningiomas, also due to the almost constant expression of hormonal receptors by tumoral cells. A case of a woman with previous history of multiple treatment for infertility, harboring a huge meningioma is here described. The tumor was surgically resected and the immunohistochemical examination revealed a high expression of progesterone receptors on tumoral cells surface. A putative role of past progesterone administration in the growth of meningioma has been hypothesized. Particular caution should be paid whenever adopting sexual hormonal therapy, especially for fertility. A radiological examination (ideally MRI) could be advised before starting therapy, in order to rule out any intracranial meningioma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426675     DOI: 10.1007/s13760-012-0046-9

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  3 in total

1.  Fertility treatment is associated with multiple meningiomas and younger age at diagnosis.

Authors:  Maryam N Shahin; Stephen T Magill; Cecilia L Dalle Ore; Jennifer A Viner; Pamela N Peters; David A Solomon; Michael W McDermott
Journal:  J Neurooncol       Date:  2019-03-13       Impact factor: 4.130

2.  Fast-Growing Meningioma in a Woman Undergoing Fertility Treatments.

Authors:  Adam Patterson; Abdurrahim Elashaal
Journal:  Case Rep Neurol Med       Date:  2016-12-26

3.  Meningiomas in Premenopausal Women: Role of the Hormone Related Conditions.

Authors:  Francesco Maiuri; Giuseppe Mariniello; Teresa Somma; Elia Guadagno; Sergio Corvino; Serena Pagano; Valentina Orlando; Marialaura Del Basso De Caro
Journal:  Front Oncol       Date:  2020-12-11       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.